The use of clinical characteristics to help prevent morcellation of leiomyosarcoma: An analysis of 491 cases.
Chan JK, Gardner AB, Thompson CA, & Kapp DS.
Am J Obstet Gynecol. 213(6):873-4. doi: 10.1016/j.ajog.2015.07.040. Epub 2015 Jul 29.
2015-12-01
Abstract
Minimally invasive surgery results in shorter recovery and improved quality of life.
The removal of the uterus or fibroids using morcellators to fragment the specimen can potentially spread unsuspected malignancy and result in poor prognosis.
Uterine leiomyosarcomas (LMS) comprise only 3% of uterine malignancies, but have similar characteristics to uterine fibroids.
Serum biomarkers and radiologic diagnostic criteria to preoperatively identify LMS have not been widely adopted.
Factors related to increased risk of LMS in patients with presumed benign leiomyoma, including older age and black race, have not been well defined.
Related publications
View all publications- Low YS, Daugherty AC, Schroeder EA, Chen W, Seto T, Weber S, Lim M, Hastie T, Mathur M, Desai M, Farrington C, Radin AA, Sirota M, Kenkare P, Thompson CA, Yu PP, Gomez SL, Sledge GW Jr, Kurian AW, Shah NH.J Am Med Inform Assoc. pii: ocw161. doi: 10.1093/jamia/ocw161. [Epub ahead of print]2016 Dec 09
- Thompson CA, Kurian AW, Luft HS.eGEMs (Generating Evidence & Methods to improve patient outcomes). 3(1).2015 Mar 01
- Liang SY, Phillips KA, Wang G, Keohane C, Armstrong J, Morris WM, Haas JS.Med Care. 49(6):e1-8. doi: 10.1097/MLR.0b013e318207e87e.2011 Jun 01
- Becker CM, Laufer MR, Stratton P, Hummelshoj L, Missmer SA, Zondervan KT, Adamson GD; WERF EPHect Working Group.Fertil Steril. 102(5):1213-22. doi: 10.1016/j.fertnstert.2014.07.709. Epub 2014 Aug 20.2014 Nov 01
- Liang SY, Grossman D, Phillips KA.Contraception. 86(6):666-72. doi: 10.1016/j.contraception.2012.05.018. Epub 2012 Jul 6.2012 Dec 01